{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:16:36Z","timestamp":1792030596822,"version":"4.4.0"},"reference-count":82,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline plc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2574129","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T18:54:30Z","timestamp":1761245670000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-5340","authenticated-orcid":false,"given":"Anar","family":"Andani","sequence":"first","affiliation":[{"name":"GSK, Medical Affairs","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Abbing-Karahagopian","sequence":"additional","affiliation":[{"name":"GSK Vaccines, Epidemiology","place":["Amsterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Kavaliauskaite","sequence":"additional","affiliation":[{"name":"GSK, Medical Affairs","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry Oliver","family":"Schaffner","sequence":"additional","affiliation":[{"name":"GSK, Medical Affairs","place":["Baar, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Yun","family":"Sohn","sequence":"additional","affiliation":[{"name":"GSK, Medical Affairs","place":["Rockville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriela","family":"Gra\u00f1a","sequence":"additional","affiliation":[{"name":"GSK Vaccines, Medical Affairs","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Marshall","sequence":"additional","affiliation":[{"name":"The University of Adelaide and Women\u2019s and Children\u2019s Health Network","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Martinon-Torres","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario de Santiago (SERGAS) and University of Santiago de Compostela (USC)","place":["Santiago de Compostela, Galicia, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS)","place":["Santiago de Compostela, Spain"]},{"name":"Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[{"name":"Fondazione Biotecnopolo di Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"ECDC. Factsheet about meningococcal disease [Internet]. 2023 [accessed 2024 Aug 29]. https:\/\/www.ecdc.europa.eu\/en\/meningococcal-disease\/factsheet."},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0213-2"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"e_1_3_6_5_1","unstructured":"GSK. \u2018Teenagers may feel invincible \u2013 but we\u2019re at high risk\u2019: what you need to know about meningitis as cases see post-COVID pandemic rebound in some countries [Internet]. 2023 [accessed 2024 Aug 29]. https:\/\/www.gsk.com\/en-gb\/behind-the-science-magazine\/meningitis-cases-rebound-risks-symptoms\/."},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0581"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12111075"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13342-2"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00546-z"},{"key":"e_1_3_6_10_1","unstructured":"ECDC. Invasive meningococcal disease - annual epidemiological report for 2022 [Internet]. 2024 [accessed 2024 Aug 29]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2022."},{"key":"e_1_3_6_11_1","unstructured":"ECDC. Surveillance atlas of infectious disease [Internet]. 2024 [accessed 2024 Aug 29]. https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/428590"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00888-w"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.04.012"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1754052"},{"key":"e_1_3_6_17_1","unstructured":"Strat\u00e9gie de vaccination pour la pr\u00e9vention des infections invasives \u00e0 m\u00e9ningocoques: le s\u00e9rogroupe B et la place de Bexsero\u00ae [Internet]. 2021 [accessed 2024 Mar 19]. http:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-06\/strategie_de_vaccination_pour_la_prevention_des_infections_invasives_a_meningocoques_le_serogroupe_b_et_la_place_de_bexsero.pdf."},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1849518"},{"key":"e_1_3_6_19_1","unstructured":"Decision no. 2024.0062\/DC\/SESPEV of March 7 2024 of the college of the High Authority of Health adopting the vaccination recommendation entitled \u201cVaccination strategy against invasive meningococcal infections: revision of the strategy against serogroups ACWY and B [Internet]. 2024 [accessed 2024 Dec 19]. https:\/\/www.has-sante.fr\/jcms\/p_3500436\/fr\/decision-n2024-0062\/dc\/sespev-du-7-mars-2024-du-college-de-la-haute-autorite-de-sante-portant-adoption-de-la-recommandation-vaccinale-intitulee-strategie-de-vaccination-contre-les-infections-invasives-a-meningocoques-revision-de-la-strategie-contre-les-serogroupes-acwy-et-b."},{"key":"e_1_3_6_20_1","unstructured":"Ministre de la Sant\u00e9. The vaccination schedule [Internet]. 2025 [accessed 2025 Sep 10]. https:\/\/sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/vaccination\/calendrier-vaccinal."},{"key":"e_1_3_6_21_1","unstructured":"World Health Organization. Defeating meningitis by 2030 [Internet]. [accessed 2024 Aug 29]. https:\/\/www.who.int\/initiatives\/defeating-meningitis-by-2030."},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2023.09.002"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2023.10.001"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106335"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2052048"},{"key":"e_1_3_6_26_1","unstructured":"Institut Pasteur. The lowdown on meningitis a public health challenge [Internet]. 2024 [accessed 2024 Oct 7]. https:\/\/www.pasteur.fr\/en\/research-journal\/reports\/lowdown-meningitis-public-health-challenge."},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757755"},{"key":"e_1_3_6_28_1","unstructured":"Federal Office of Public Health BAG. Invasive meningococcal diseases [Internet]. 2025 [accessed 2025 Oct 14]. https:\/\/www.bag.admin.ch\/en\/meningococcal-disease#Prevention."},{"key":"e_1_3_6_29_1","unstructured":"JEP CVS\u010c. Recommendations of the Czech Vaccinological Society \u010cLS JEP for vaccination against invasive meningococcal disease [Internet]. 2024 [accessed 2025 Feb 16]. https:\/\/vakcinace.eu\/doporuceni-a-stanoviska\/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-pro-ockovani-proti-invazivnim-meningokokovym-1."},{"key":"e_1_3_6_30_1","unstructured":"ECDC. Meningococcal disease: Recommended vaccinations [Internet]. [accessed 2024 Oct 7]. https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=48&SelectedCountryIdByDisease=-1."},{"key":"e_1_3_6_31_1","unstructured":"Bundesministerium. Impfplan \u00d6sterreich 2024\/2025 [Internet]. 2024 [accessed 2025 Feb 16]. https:\/\/www.sozialministerium.at\/dam\/jcr:0ba20816-f461-4dd7-a2b2-04d3b6da5a9c\/Impfplan-Tabelle-2024-2025_1-1.pdf."},{"key":"e_1_3_6_32_1","unstructured":"Superior Health Council. Meningococcal vaccination (SHC-9485 2019 update) [Internet]. 2019 [accessed 2025 Feb 16]. https:\/\/www.hgr-css.be\/en\/report\/9485\/meningococcal-vaccination."},{"key":"e_1_3_6_33_1","unstructured":"Folkehelseinstituttet. Youth recommended vaccination against infectious meningitis [Internet]. 2024 [accessed 2025 Feb 16]. https:\/\/www.fhi.no\/ss\/hjernehinnebetennelse\/vaksine-mot-smittsom-hjernehinnebetennelse\/ungdom-bor-vurdere-a-vaksinere-seg-mot-smittsom-hjernehinnebetennelse\/#pris."},{"key":"e_1_3_6_34_1","unstructured":"Chief Sanitary Inspectorate. National vaccination program as of 2023 [Internet]. 2022 [accessed 2025 Feb 16]. https:\/\/dziennikmz.mz.gov.pl\/DUM_MZ\/2022\/113\/oryginal\/akt.pdf."},{"key":"e_1_3_6_35_1","unstructured":"Emilia-Romagna Region. Approval of the Emilia-Romagna regional plan for vaccination prevention 2023-2025 [Internet]. 2023 [accessed 2025 Apr 30]. https:\/\/servizissiir.regione.emilia-romagna.it\/deliberegiunta\/servlet\/AdapterHTTP?action_name=ACTIONRICERCADELIBERE&operation=leggi&cod_protocollo=GPG\/2023\/2277&ENTE=1."},{"key":"e_1_3_6_36_1","unstructured":"Trova Norme Salute. Presidency of the Council of Ministers Permanent Conference for Relations between the State the Regions and the Autonomous Provinces [Internet]. 2023 [accessed 2025 Apirl 30]. https:\/\/www.trovanorme.salute.gov.it\/norme\/dettaglioAtto?id=95963&completo=true."},{"key":"e_1_3_6_37_1","unstructured":"Veneto Region - Regional Council. Vaccination schedule [Internet]. 2015 [accessed 2025 Apr 30]. https:\/\/www.vaccinarsinveneto.org\/vaccinazioni-veneto\/calendario-vaccinale."},{"key":"e_1_3_6_38_1","unstructured":"University of Genoa - Department of Health Sciences (DISSAL). The vaccination schedule of the Liguria region [Internet]. 2024 [accessed 2025 Apr 30]. https:\/\/www.vaccinarsinliguria.org\/vaccinazioni-liguria\/calendario-vaccinale."},{"key":"e_1_3_6_39_1","unstructured":"Northern Territory Government. Meningococcal disease [Internet]. 2025 [accessed 2025 Feb 6]. https:\/\/nt.gov.au\/wellbeing\/health-conditions-treatments\/bacterial\/meningococcal-disease."},{"key":"e_1_3_6_40_1","unstructured":"Australian Government - Department of Health and Aged Care. Meningococcal vaccine [Internet]. 2024 [accessed 2024 Oct 7]. https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-services\/meningococcal-immunisation-service."},{"key":"e_1_3_6_41_1","unstructured":"Pharmac. Pharmaceutical schedule [Internet]. 2024 [accessed 2024 Oct 7]. https:\/\/schedule.pharmac.govt.nz\/2024\/10\/01\/Schedule.pdf."},{"key":"e_1_3_6_42_1","unstructured":"Bio-Manguinhos\/Fiocruz. Fiocruz and Funed receive Anvisa\u2019s registration for meningococcal vaccine [Internet]. 2023 [accessed 2024 Oct 7]. https:\/\/portal.fiocruz.br\/en\/news\/fiocruz-and-funed-receive-anvisas-registration-meningococcal-vaccine#:~:text=The."},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029087"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2019.03.018"},{"key":"e_1_3_6_45_1","unstructured":"Sant\u00e9 Publique France. Vaccination in France. Assessment of vaccination coverage in 2023 [Internet]. 2024 [accessed 2024 Oct 9]. https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/documents\/bulletin-national\/vaccination-en-france.-bilan-de-la-couverture-vaccinale-en-2023."},{"key":"e_1_3_6_46_1","unstructured":"STIKO. Recommendations of the Standing Committee on Vaccination [Internet]. 2025 [accessed 2025 Oct 14]. https:\/\/www.rki.de\/EN\/Topics\/Infectious-diseases\/Immunisation\/STIKO\/STIKO-recommendations\/recommendations_content.html."},{"key":"e_1_3_6_47_1","unstructured":"Robert Koch Institut. Epidemiologisches bulletin 48\/2022 [Internet]. 2022 [accessed 2025 Mar 26]. https:\/\/www.rki.de\/DE\/Aktuelles\/Publikationen\/Epidemiologisches-Bulletin\/2022\/48_22.html."},{"key":"e_1_3_6_48_1","unstructured":"Ministero della Salute. Vaccinazioni dell\u2019adolescente. Anno 2022 (coorte 2006 - 16 anni) [Internet]. 2023 [accessed 2024 Oct 9]. https:\/\/www.salute.gov.it\/imgs\/C_17_bancheDati_38_0_5_file.pdf."},{"key":"e_1_3_6_49_1","unstructured":"Ministero della Salute. Coperture vaccinali al 31.12.2022 per HPV [Internet]. 2022 [accessed 2025 Mar 26]. https:\/\/www.salute.gov.it\/new\/it\/banche-dati\/vaccinazione-contro-il-papilloma-virus-hpv-coperture-vaccinali\/."},{"key":"e_1_3_6_50_1","unstructured":"Raphael Lichten. Papillomavirus: Vaccination campaign not taking off [Internet]. 2024 [accessed 2024 Oct 9]. https:\/\/www.jim.fr\/viewarticle\/papillomavirus-campagne-vaccination-ne-prend-pas-2024a10002zh."},{"key":"e_1_3_6_51_1","unstructured":"Ministerio de Sanidad. Sivamin - cobertura de vacunacion [Internet]. 2023 [accessed 2024 Oct 9]. https:\/\/pestadistico.inteligenciadegestion.sanidad.gob.es\/publicoSNS\/I\/sivamin\/sivamin."},{"key":"e_1_3_6_52_1","unstructured":"AEPap. Calendario vacunacion [Internet]. 2025 [accessed 2025 May 8]. https:\/\/aepap.org\/calendario_vacunacion\/."},{"key":"e_1_3_6_53_1","unstructured":"Institute of Health Information and Statistics of the Czech Republic. Vaccination in available NZIS data [Internet]. 2025 [accessed 2025 Aug 25]. https:\/\/www.nzip.cz\/data\/1703-proockovanost-kraje-okresy-datovy-souhrn."},{"key":"e_1_3_6_54_1","unstructured":"JEP CVS\u010c. Vaccination calendar [Internet]. 2024 [accessed 2025 Aug 25]. https:\/\/www.vakcinace.eu\/ockovani-v-cr-odb."},{"key":"e_1_3_6_55_1","unstructured":"UK Health Security Agency. Human papillomavirus (HPV) vaccination coverage in adolescents in England: 2023 to 2024 [Internet]. 2025 [accessed 2025 Feb 16]. https:\/\/www.gov.uk\/government\/statistics\/human-papillomavirus-hpv-vaccine-coverage-estimates-in-england-2023-to-2024\/human-papillomavirus-hpv-vaccination-coverage-in-adolescents-in-england-2023-to-2024."},{"key":"e_1_3_6_56_1","unstructured":"UK Health Security Agency. Seasonal influenza vaccine uptake in GP patients in England: Winter season 2023 to 2024 [Internet]. 2024 [accessed 2024 Oct 9]. https:\/\/www.gov.uk\/government\/statistics\/seasonal-influenza-vaccine-uptake-in-gp-patients-winter-season-2023-to-2024\/seasonal-influenza-vaccine-uptake-in-gp-patients-in-england-winter-season-2023-to-2024#table5."},{"key":"e_1_3_6_57_1","unstructured":"UK Health Security Agency. Meningococcal ACWY (MenACWY) vaccine coverage for adolescents in England academic year 2023 to 2024 [Internet]. 2025 [accessed 2025 Feb 16]. https:\/\/www.gov.uk\/government\/publications\/meningococcal-acwy-immunisation-programme-vaccine-coverage-estimates\/meningococcal-acwy-menacwy-vaccine-coverage-for-adolescents-in-england-academic-year-2023-to-2024."},{"key":"e_1_3_6_58_1","unstructured":"Federal Office of Public Health. Swiss vaccination plan [Internet]. 2025 [accessed 2025 Sep 10]. https:\/\/www.bag.admin.ch\/de\/schweizerischer-impfplan#Der-Schweizerische-Impfplan."},{"key":"e_1_3_6_59_1","unstructured":"Federal Office of Public Health BAG. Vaccination coverage of 2- 8- and 16-year-old children and adolescents in Switzerland 2020-2022 [Internet]. 2024 [accessed 2025 Oct 14]. https:\/\/www.bag.admin.ch\/dam\/de\/sd-web\/XW9RQECXiyCA\/bu-13-24.pdf."},{"key":"e_1_3_6_60_1","unstructured":"National Centre for Immunisation Research and Surveillance Australia. Annual immunisation coverage report 2022 [Internet]. 2023. [accessed 2024 Oct 9]. https:\/\/ncirs.org.au\/sites\/default\/files\/2024-01\/NCIRS%20Annual%20immunisation%20coverage%20report%202022.pdf."},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf372"},{"key":"e_1_3_6_62_1","unstructured":"Brasil Ministry of Health. Vaccination calendar [Internet]. 2024 [accessed 2024 Oct 9]. https:\/\/www.gov.br\/saude\/pt-br\/vacinacao\/calendario."},{"key":"e_1_3_6_63_1","unstructured":"Minist\u00e9rio da Sa\u00fade. Falling HPV vaccination coverage poses risk of increased cases of preventable cancers in Brazil. [Internet]. 2023 [accessed 2024 Oct 9]. https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2023\/fevereiro\/queda-da-cobertura-vacinal-contra-o-hpv-representa-risco-de-aumento-de-casos-de-canceres-evitaveis-no-brasil#:~:text=Em%202019%2C%2087%2C08%25 52%2C16%25%20em%202022."},{"key":"e_1_3_6_64_1","unstructured":"Brazilian Society of Immunizations. Calendario de vacinacao SBIM - Adolescente [Internet]. [accessed 2024 Oct 9]. https:\/\/sbim.org.br\/images\/calendarios\/calend-sbim-adolescente.pdf."},{"key":"e_1_3_6_65_1","unstructured":"Health New Zealand. HPV immunisation coverage of 2011 birth cohort to 30 June 2024 [Internet]. 2024 [accessed 2024 Oct 9]. https:\/\/www.tewhatuora.govt.nz\/health-services-and-programmes\/vaccine-information\/hpv-immunisation-programme."},{"key":"e_1_3_6_66_1","unstructured":"National Administration Principality of Liechtenstein. Vaccinations [Internet]. 2025 [accessed 2025 Sep 9]. https:\/\/www.llv.li\/en\/individuals\/health-care-and-care\/health-and-prevention\/vaccination."},{"issue":"4","key":"e_1_3_6_67_1","first-page":"243","article-title":"Analysis of meningococcal vaccine uptake in patients with invasive meningococcal disease, Czech Republic, 2006-2022","volume":"72","author":"Krizova P","year":"2023","unstructured":"Krizova P, Okonji Z, Honskus M. Analysis of meningococcal vaccine uptake in patients with invasive meningococcal disease, Czech Republic, 2006-2022. Epidemiol Mikrobiol Imunol. 2023;72(4):243\u2013247.","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1949292"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.2196\/17187"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2186111"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1923349"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02492-9"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.02.018"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.11.078"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2009.01494.x"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7322e1"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000726"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491513000306"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2222015"},{"key":"e_1_3_6_80_1","unstructured":"GSK. Penmenvy GSK\u2019s 5-in-1 meningococcal vaccine approved by US FDA to help protect against MenABCWY. [Internet]. 2025 [accessed 2025 Mar 19]. https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/penmenvy-gsk-s-5-in-1-meningococcal-vaccine-approved-by-us-fda-to-help-protect-against-menabcwy\/."},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.6145"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-76891-z"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.2196\/47979"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2574129","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2574129","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2574129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:35:29Z","timestamp":1786034129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2574129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2574129"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2574129","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2574129"}}